RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

Clinical trial NCT03684564 · COMPLETED

Trial details

NCT number: NCT03684564
Sponsor: University College, London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Antiphospholipid Syndrome Systemic Lupus Erythematosus Stroke Ischemic Stroke Brain Ischemia

Start date: 2021-07-09
Primary completion: 2025-07-31
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.